8 / 23
Page 52
Journal of Medical Physics and Applied Sciences
ISSN: 2574-285X
I n t e r n a t i o n a l C o n f e r e n c e o n
Nuclear Medicine &
Radiation Therapy
Nuclear Medicine & Radiation Therapy 2018
O c t o b e r 0 1 - 0 2 , 2 0 1 8
S t o c k h o l m , S w e d e n
R
adioactive iodine ablations (RAI) with Iodine-131 (
131
I ) have been performed for decades in several countries. This presentation
will provide a review of regulatory requirements for management of these patients and compare requirements around the
world. Following the presentation, the attendee will have met the following objectives: review thyroid cancer types and treatment
options; review regulatory requirements related to
131
I treatment: determination, instructions, written directives, release. I will
share my experience as a member of a team that provided training in Lusaka, Zambia in Jul’ 2017.
jessicaclements@gmail.comIodine-131 requirements from A to Z (America to
Zambia)
Jessica Clements
Southern California Permanente Medical Group, USA
J. med phys & appl sci 2018, Volume: 3
DOI: 10.21767/2574-285X-C1-003